mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.2 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |